 Eyenovia, Inc. EYEN, a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced that Professor Mark Bullimore, PhD and April Jasper, OD have joined Eyenovias Scientific Advisory Board. We are very pleased to welcome two highly accomplished and respected optometrists to our Scientific Advisory Board, commented Dr. Sean Ianchulev, Eyenovias Chief Executive Officer and Chief Medical Officer. 